Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 9:00 pm Sale |
2024-09-30 | 13G | Repare Therapeutics Inc. RPTX |
Redmile Group LLC | 1,942,555 4.600% |
-206,193 (-9.60%) |
Filing History |
| 2024-10-04 5:00 pm Sale |
2024-10-02 | 13D | Augmedix, Inc. AUGX |
Redmile Group LLC | 0 0.000% |
-22,131,580 (Position Closed) |
Filing History |
| 2024-09-13 4:01 pm Purchase |
2024-09-03 | 13G | Atara Biotherapeutics, Inc. ATRA |
Redmile Group LLC | 579,541 9.900% |
167,485 (+40.65%) |
Filing History |
| 2024-07-19 7:45 pm Purchase |
2024-07-19 | 13D | Augmedix, Inc. AUGX |
Redmile Group LLC | 22,131,580 40.500% |
39,369 (+0.18%) |
Filing History |
| 2024-03-25 5:15 pm Purchase |
2024-03-21 | 13D | Fate Therapeutics, Inc. FATE |
Redmile Group LLC | 17,619,095 14.900% |
2,569,256 (+17.07%) |
Filing History |
| 2024-03-13 5:15 pm Sale |
2024-03-12 | 13D | Science 37 Holdings, Inc. SNCE |
Redmile Group LLC | 0 0.000% |
-994,529 (Position Closed) |
Filing History |
| 2024-03-05 5:15 pm Purchase |
2024-03-01 | 13D | Absci Corporation ABSI |
Redmile Group LLC | 8,282,016 7.400% |
250,922 (+3.12%) |
Filing History |
| 2024-02-14 4:26 pm Purchase |
2023-12-31 | 13G | ADC Therapeutics SA ADCT |
Redmile Group LLC | 15,328,317 18.800% |
1,763,068 (+13.00%) |
Filing History |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | ALX Oncology Holdings Inc. ALXO |
Redmile Group LLC | 4,909,264 9.600% |
-82,281 (-1.65%) |
Filing History |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
Redmile Group LLC | 1,109,476 2.000% |
-1,523,436 (-57.86%) |
Filing History |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | Entrada Therapeutics, Inc. TRDA |
Redmile Group LLC | 1,283,735 3.800% |
-570,373 (-30.76%) |
Filing History |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | HOOKIPA Pharma Inc. HOOK |
Redmile Group LLC | 106,377 1.100% |
-439,700 (-80.52%) |
Filing History |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | Krystal Biotech, Inc. KRYS |
Redmile Group LLC | 1,733,189 6.100% |
-163,456 (-8.62%) |
Filing History |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | LAVA Therapeutics N.V. LVTX |
Redmile Group LLC | 2,074,372 7.900% |
-741,824 (-26.34%) |
Filing History |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Redmile Group LLC | 2,696,648 4.500% |
-1,181,951 (-30.47%) |
Filing History |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | REGENXBIO Inc. RGNX |
Redmile Group LLC | 3,760,690 8.600% |
-477,622 (-11.27%) |
Filing History |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | Repare Therapeutics Inc. RPTX |
Redmile Group LLC | 2,148,748 5.100% |
-535,648 (-19.95%) |
Filing History |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | Stereotaxis, Inc. STXS |
Redmile Group LLC | 3,402,443 4.200% |
-3,695,173 (-52.06%) |
Filing History |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | Stoke Therapeutics, Inc. STOK |
Redmile Group LLC | 2,625,506 5.900% |
-1,541,469 (-36.99%) |
Filing History |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | Zymeworks Inc. ZYME |
Redmile Group LLC | 5,790,230 8.300% |
-385,688 (-6.25%) |
Filing History |